Tidepool, ŌURA partner to scale diabetes data 

PALO ALTO, Calif. - Tidepool, a provider of diabetes software, has announced a strategic collaboration with ŌURA to support a groundbreaking dataset that they intend to make available for diabetes research. With participant consent and authorized disclosure, Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The companies say this will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology and personalized care models. "For too long, diabetes research has overlooked critical physiological factors that impact health, especially for women," said Kelly Watson, VP of product and user experience at Tidepool. "This collaboration with ŌURA is a pivotal step toward closing that gap and unlocking new avenues for innovation. By creating a dataset of this scale and detail, we are giving researchers the tools they need to answer long-overdue questions and, ultimately, reduce the daily burden of diabetes.” Recruitment is expected to launch in early 2026 through an International Review Board-approved study. By opting in to this study, participants consent to sharing their data with Tidepool’s Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers and industry innovators to accelerate diabetes research. "Our mission is to empower individuals to take proactive ownership of their health, and we’re proud to support Tidepool in extending that mission to the diabetes community," said Shyamal Patel, SVP of Science of ŌURA. "The resulting dataset will provide the scientific community with a new foundation for understanding how biometric trends intersect with diabetes management. We believe this collaboration will not only fuel groundbreaking discoveries but also empower individuals with a more complete picture of their health, changing the landscape of diabetes management."